Hypoxia then stimulates the release of anti-angiogenic factors, such as soluble Fms-like tyrosine kinase-1 (sFlt-1), which further aggravates vascular dysfunction and perpetuates a cycle of inflammation, vasoconstriction, and multiorgan damage characteristic of preeclampsia [15]. This evidence concerns the gene FLT1 and preeclampsia.